Exact Mass: 416.1325

Exact Mass Matches: 416.1325

Found 125 metabolites which its exact mass value is equals to given mass value 416.1325, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

2-Hydroxybenzaldehyde O-[xylosyl-(1->6)-glucoside]

2-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl)oxy]benzaldehyde

C18H24O11 (416.1319)

2-Hydroxybenzaldehyde O-[xylosyl-(1->6)-glucoside] is found in alcoholic beverages. 2-Hydroxybenzaldehyde O-[xylosyl-(1->6)-glucoside] is isolated from Filipendula ulmaria (meadowsweet). Isolated from Filipendula ulmaria (meadowsweet). 2-Hydroxybenzaldehyde O-[xylosyl-(1->6)-glucoside] is found in tea and alcoholic beverages.

Halopemide

N-{2-[4-(5-chloro-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-1-yl)piperidin-1-yl]ethyl}-4-fluorobenzamide

C21H22ClFN4O2 (416.1415)

C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Halopemide is a potent phospholipase D (PLD) inhibitor, with IC50s of 220 and 310 nM for human PLD1 and PLD2, respectively. Halopemid is a dopamine receptors antagonist, and acts a psychotropic agent[1][2]. Halopemide is a potent phospholipase D (PLD) inhibitor, with IC50s of 220 and 310 nM for human PLD1 and PLD2, respectively. Halopemid is a dopamine receptors antagonist, and acts a psychotropic agent[1][2].

1-(2-Chloro-4-(6,7-dimethoxyquinazolin-4-yloxy)phenyl)-3-propylurea

N-(2-Chloro-4-((6,7-dimethoxy-4-quinazolinyl)oxy)phenyl)-n-propylurea

C20H21ClN4O4 (416.1251)

alpinoside

C18H24O11 (416.1319)

O-Acetylgeniposidic acid

10-O-Acetylgeniposidic acid

C18H24O11 (416.1319)

Regaloside C

[(2S)-2-Hydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C18H24O11 (416.1319)

Regaloside C is a natural product found in Lilium henryi, Lilium brownii, and other organisms with data available. Regaloside C is a glycerol glucoside isolated from the bulbs of?Lilium genus with anti-inflammatory activities. Regaloside C has cardiomyocyte protective activity by protecting the mitochondria in H2O2-induced heart H9C2 cells[1].

12-dehydroxychaetomugilin N|chaetomugilin O

C23H25ClO5 (416.139)

4-[O-alpha-apiofuranosyl-(1->2)-beta-D-glucopyranosyloxy]benzaldehyde

C18H24O11 (416.1319)

15-O-deacetylrhaposerin|cebellin J

C19H25ClO8 (416.1238)

regaloside L

C18H24O11 (416.1319)

4-O-(3,4-Dihydroxycinnamoyl)-beta-D-(2R)-1-O-Glucopyranosylglycerol

C18H24O11 (416.1319)

5a,6-Dihydro-3-(1H-indol-3-yl)-1,4-dimethoxy-10bH-benzofuro[2,3-b]indole-2,10b-diol

C24H20N2O5 (416.1372)

1-O-beta-D-(3-caffeoyl)glucopyranosylglycerol

C18H24O11 (416.1319)

vernchinilide C

C19H25ClO8 (416.1238)

Interruptin C

C25H20O6 (416.126)

C18H24O11

C18H24O11 (416.1319)

1-O-beta-D-(6-caffeoyl)glycopyranosylglycerol

C18H24O11 (416.1319)

beta-D-xylopyranosyl(1->2)-7-O-benzoyl-beta-D-glucopyranoside

C18H24O11 (416.1319)

C23H25ClO5

C23H25ClO5 (416.139)

Regaloside K

C18H24O11 (416.1319)

[(2S)-3-hydroxy-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate is a natural product found in Lilium mackliniae with data available.

(7R)-8-[1-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-yl]chrysin

C25H20O6 (416.126)

(3Z)-6,7-dihydroxy-4-methoxy-3-(phenylmethylidene)-5-(3-phenylpropanoyl)-1-benzofuran-2(3H)-one|bractelactone

C25H20O6 (416.126)

Halopemide

N-[2-[4-(5-chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-ethyl]-4-fluoro-benzamide

C21H22ClFN4O2 (416.1415)

Zuclopenthixol sulfoxide

C22H25ClN2O2S (416.1325)

Spiraein (filipendula)

2-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl)oxy]benzaldehyde

C18H24O11 (416.1319)

Decamethonium Bromide

C16H38Br2N2 (416.1402)

Decamethonium Bromide is a nicotinic AChR partial agonist and neuromuscular blocking agent. Target: nAChR Decamethonium (Syncurine) is a depolarizing muscle relaxant or neuromuscular blocking agent, and is used in anesthesia to induce paralysis. Decamethonium, which has a short action time, is similar to acetylcholine and acts as a partial agonist of the nicotinic acetylcholine receptor. In the motor endplate, it causes depolarization, preventing further effects to the normal release of acetylcholine from the presynaptic terminal, and therefore preventing the neural stimulus from affecting the muscle. In the process of binding, decamethonium actually activates (depolarizes) the motor endplate, but since the decamethonium itself is not degraded, the membrane remains depolarized and unresponsive to normal acetylcholine release [1].

2-(Methylthio)-4-(tributylstannyl)pyrimidine

C17H32N2SSn (416.1308)

2-Methylthio-5-(tributylstannyl)pyrimidine

C17H32N2SSn (416.1308)

4-(1-(3-FLUOROBENZYL)-1H-INDAZOL-5-YLAMINO)-5-METHYLPYRROLO[1,2-F][1,2,4]TRIAZINE-6-CARBOXYLIC ACID

C22H17FN6O2 (416.1397)

KRN-633

VEGF receptor tyrosine kinase inhibitor III

C20H21ClN4O4 (416.1251)

L-741,742 hydrochloride,5-(4-Chlorophenyl)-4-methyl-3-(1-(2-phenylethyl)piperidin-4-yl)isoxazolehydrochloride

C23H26Cl2N2O (416.1422)

Nicosulfuron-d6

C15H12D6N6O6S (416.1385)

Phosphonicacid, [(phenylamino)-4-pyridinylmethyl]-, diphenyl ester (9CI)

C24H21N2O3P (416.129)

1H-1,2,4-Triazole-1-propanamide, 3-((2,2-difluoro-1,3-benzodioxol-5-yl)amino)-N,N-dimethyl-5-(4-pyridinyl)-

C19H18F2N6O3 (416.1408)

N-(1,3-benzodioxol-5-ylmethyl)-4-methyl-3-(1-piperidinylsulfonyl)benzamide

C21H24N2O5S (416.1406)

2-[(4,6-dimethyl-2-pyrimidinyl)thio]-N-(4,5-diphenyl-2-oxazolyl)acetamide

C23H20N4O2S (416.1307)

9-hydroxy-6-(3-hydroxypropyl)-4-(2-methoxyphenyl)pyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione

C24H20N2O5 (416.1372)

[(4S,5R,6S,8S,10R)-10-[(S)-(2,4-dioxo-1H-pyrimidin-6-yl)-hydroxymethyl]-5-methyl-2,11-diaza-12-azoniatricyclo[6.3.1.04,12]dodec-1(12)-en-6-yl] hydrogen sulfate

C15H22N5O7S+ (416.124)

[(4S,5R,6S,8S,10R)-10-[(R)-(2,4-dioxo-1H-pyrimidin-6-yl)-hydroxymethyl]-5-methyl-2,11-diaza-12-azoniatricyclo[6.3.1.04,12]dodec-1(12)-en-6-yl] hydrogen sulfate

C15H22N5O7S+ (416.124)

Chaetoviridin G

C23H25ClO5 (416.139)

An azaphilone that is 9,9a-dihydro-6H-furo[2,3-h]isochromene-6,8(6aH)-dione substituted by a chloro group at position 5, a methyl group at position 6a, a 2-methylbut-2-enoyl group at position 9 and a 3-methylpent-1-en-1-yl group at position 3. It has been isolated from Chaetomium globosum.

4-Epichaetoviridin F

C23H25ClO5 (416.139)

An azaphilone that is 6H-furo[2,3-h]isochromene-6,8(6aH)-dione substituted by a chloro group at position 5, a methyl group at position 6a, a 2-methylbutanoyl group at position 9 and a 3-methylpent-1-en-1-yl group at position 3. It has been isolated from Chaetomium globosum.

2-(1,3-benzodioxol-5-ylmethyl)-3-(2,3-dihydro-1,4-benzodioxin-6-ylamino)-3H-isoindol-1-one

C24H20N2O5 (416.1372)

N-(1-isoquinolinyl)-4-[3-(trifluoromethyl)phenyl]-1-piperazinecarbothioamide

C21H19F3N4S (416.1282)

3-[[4-(2-Benzofuranyl)-2-thiazolyl]methyl]-2-[(dimethylamino)methyl]-4-quinazolinone

C23H20N4O2S (416.1307)

3-oxo-4H-1,4-benzothiazine-6-carboxylic acid [2-[1-(1-methoxypropan-2-yl)-2,5-dimethyl-3-pyrrolyl]-2-oxoethyl] ester

C21H24N2O5S (416.1406)

2,3-Dihydro-1,4-benzodioxin-3-yl-[4-(3,4-dimethylphenyl)sulfonyl-1-piperazinyl]methanone

C21H24N2O5S (416.1406)

4-[[3-[(2-methoxyphenyl)carbamoyl]-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophen-2-yl]amino]-4-oxobutanoic acid

C21H24N2O5S (416.1406)

12-oxo-N-(4-phenyl-2-thiazolyl)-7,8,9,10-tetrahydro-6H-azepino[2,1-b]quinazoline-3-carboxamide

C23H20N4O2S (416.1307)

Succinic acid, 2,2,3,3,4,4,5,5-octafluoropentyl 2-methylpent-3-yl ester

C15H20F8O4 (416.1234)

N-[5-[2-(2-methoxyanilino)-4-thiazolyl]-4-methyl-2-thiazolyl]-2-methylpentanamide

C20H24N4O2S2 (416.1341)

2-[(3S,6aR,8S,10aR)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

2-[(3S,6aS,8R,10aS)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

2-[(1S,3S,4aS,9aR)-6-[[(4-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C21H21FN2O6 (416.1384)

2-[(1S,3S,4aR,9aS)-6-[[(4-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C21H21FN2O6 (416.1384)

2-[(1S,3R,4aR,9aS)-6-[[(4-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C21H21FN2O6 (416.1384)

2-[(3R,6aR,8S,10aR)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

2-[(3S,6aS,8S,10aS)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

2-[(1R,3R,4aR,9aS)-6-[[(4-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C21H21FN2O6 (416.1384)

2-[(1S,3R,4aS,9aR)-6-[[(4-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C21H21FN2O6 (416.1384)

2-[(1R,3R,4aS,9aR)-6-[[(4-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C21H21FN2O6 (416.1384)

2-[(1R,3S,4aS,9aR)-6-[[(4-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C21H21FN2O6 (416.1384)

2-[(3R,6aR,8R,10aR)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

2-[(3S,6aR,8R,10aR)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

2-[(3R,6aS,8S,10aS)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

2-[(3R,6aS,8R,10aS)-1-[(3,4-dichlorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-methylacetamide

C19H26Cl2N2O4 (416.127)

4-(3-Methoxybenzoyl)-5-(4-methoxyphenyl)-1-pyridin-2-ylpyrrolidine-2,3-dione

C24H20N2O5 (416.1372)

[(S)-3-[[(2E)-3-(3,4-Dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-2-hydroxypropyl]beta-D-glucopyranoside

C18H24O11 (416.1319)

2-Hydroxybenzaldehyde O-[xylosyl-(1->6)-glucoside]

C18H24O11 (416.1319)

4'-epichaetoviridin f

C23H25ClO5 (416.139)

(8r,9r)-8-benzyl-5,8,9-trihydroxy-6-methyl-4-phenyl-9h-furo[2,3-h]chromen-2-one

C25H20O6 (416.126)

(2r)-1-hydroxy-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C18H24O11 (416.1319)

1-hydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C18H24O11 (416.1319)

3-hydroxy-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propyl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C18H24O11 (416.1319)

2-[(2e)-but-2-en-2-yl]-4-hydroxy-5-methylphenyl 2-[(2e)-but-2-en-2-yl]-3-chloro-4,6-dihydroxy-5-methylbenzoate

C23H25ClO5 (416.139)

5-[(2e)-but-2-en-2-yl]-3-hydroxy-2-methylphenyl 2-[(2e)-but-2-en-2-yl]-3-chloro-4,6-dihydroxy-5-methylbenzoate

C23H25ClO5 (416.139)

(1r,9r)-5-(1h-indol-3-yl)-3,6-dimethoxy-8-oxa-10-azatetracyclo[7.7.0.0²,⁷.0¹¹,¹⁶]hexadeca-2,4,6,11,13,15-hexaene-1,4-diol

C24H20N2O5 (416.1372)

10-O-acetylgeniposidic acid

C18H24O11 (416.1319)

{"Ingredient_id": "HBIN000178","Ingredient_name": "10-O-acetylgeniposidic acid","Alias": "NA","Ingredient_formula": "C18H24O11","Ingredient_Smile": "CC(=O)OCC1=CCC2C1C(OC=C2C(=O)O)OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "416.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "39936","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101996850","DrugBank_id": "NA"}